Combined use of anticoagulant and antiplatelet on outcome after stroke in patients with nonvalvular atrial fibrillation and systemic atherosclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Combined use of anticoagulant and antiplatelet on outcome after stroke in patients with nonvalvular atrial fibrillation and systemic atherosclerosis ; volume:14 ; number:1 ; day:3 ; month:1 ; year:2024 ; pages:1-10 ; date:12.2024
Scientific reports ; 14, Heft 1 (3.1.2024), 1-10, 12.2024
- Creator
-
Heo, JoonNyung
Lee, Hyungwoo
Lee, Il Hyung
Lim, In Hwan
Hong, Soon-Ho
Shin, Joonggyeong
Nam, Hyo Suk
Kim, Young Dae
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-51013-3
- URN
-
urn:nbn:de:101:1-2024031814283654227455
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heo, JoonNyung
- Lee, Hyungwoo
- Lee, Il Hyung
- Lim, In Hwan
- Hong, Soon-Ho
- Shin, Joonggyeong
- Nam, Hyo Suk
- Kim, Young Dae
- SpringerLink (Online service)
Other Objects (12)
Assessing physicians’ knowledge, attitude, and practice on anticoagulant therapy in non-valvular atrial fibrillation: Syrian insights
Direct vitamin k antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation
The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) : Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis
Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study
Assessing physicians’ knowledge, attitude, and practice on anticoagulant therapy in non-valvular atrial fibrillation: Syrian insights
Direct vitamin k antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation
The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) : Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis
Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study
Assessing physicians’ knowledge, attitude, and practice on anticoagulant therapy in non-valvular atrial fibrillation: Syrian insights
Direct vitamin k antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation
The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) : Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis
Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs